Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from Elite Pharmaceuticals (ELTP).
Elite Pharmaceuticals, Inc. has announced the launch of its generic methotrexate sodium 2.5 mg tablets, an addition to the company’s product line that is expected to make waves in the pharmaceutical market. This new offering, which falls under the Elite Laboratories, Inc. brand, could be of interest to investors tracking developments in the healthcare sector and looking for potential impacts on the company’s stock performance.
For an in-depth examination of ELTP stock, go to TipRanks’ Stock Analysis page.
